This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
01 March 2025 -- GSK plc (LSE/NYSE: GSK) today announced full results from the p...
Richmond, VA, February 24, 2025 – Indivior PLC (Nasdaq/LSE: INDV), a global lead...
FDA Updates Izervay Label to Lengthen Treatment Duration for Geographic Atrophy ...
Why the Trump administration’s messaging on the Texas measles outbreak strikes s...
In this edition of STAT's Health Tech newsletter: Google gets an FDA clearance, ...
LMU researchers have shown that a particular type of immune cell acts more flexi...
The latest biotech updates, brought to you by The Readout newsletter.
GSK plc (LSE/NYSE: GSK) announced that it has completed the acquisition of IDRx,...
Working toward more effective tuberculosis (TB) vaccines, researchers at Weill C...
Vaccines to treat cancers have been around since 2010, the first being approved ...
New research suggests that antidepressants can accelerate cognitive decline in p...
Francis Collins, former longtime director of the National Institutes of Health, ...
CMS is facing employee firings, flagging morale, confusing messaging, and the sp...
A peer reviewer questioned the premise of our study into the potential impact of...
MELVILLE, N.Y., Feb. 20, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc....
CHICAGO—February 25, 2025—Emalex Biosciences announced positive topline data fro...
Berlin, Germany, and Cambridge, MA, USA February 27, 2025 – Bayer AG and BlueRoc...
Audience: Consumer Natural Dior LLC (USA) – February 25, 2025 – Natural ...
FRIDAY, Feb. 28, 2025 -- Few parents say their teen has asked about nonsurgical...
February 27, 2025 -- ALK (ALKB:DC / OMX: ALK B) today announced that the US Food...
The U.S. Food and Drug Administration is providing an at-a-glance summary of new...
2025 bracket Welcome to STAT Madness, a bracket-style contest to find the best i...
During a quarterly conference call, as Apellis Pharmaceuticals discussed its pla...
The Department of Health and Human Services is reevaluating a $590 million contr...